PDS Biotechnology (PDSB) Cash from Investing Activities (2014 - 2024)
PDS Biotechnology's (PDSB) quarterly Cash from Investing Activities came in at -$1.0 in Q3 2024, down 100.0% on a QoQ basis from $275001.0 in Q4 2019.
PDS Biotechnology (PDSB) Cash from Investing Activities (2014 - 2024) Analysis & Trends
PDS Biotechnology (PDSB) has 6 years of Cash from Investing Activities data on file, last reported at -$1.0 in Q3 2024.
- Quarterly Cash from Investing Activities changed N/A year-over-year to -$1.0 in Q3 2024, while the trailing twelve-month figure through Dec 2025 was -$1.0 (changed 0.0% YoY) and the FY2024 annual result came in at -$29000.0, changed N/A from the prior year.
- Cash from Investing Activities slipped to -$1.0 in Q3 2024, from $275001.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$1.0 in Q3 2024 to a low of -$1.0 in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | PDS Biotechnology | 12.02 Mn | 12.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | -1.00 |
| Sep 30, 2024 | -1.00 |
| Dec 31, 2019 | 275,001.00 |
| Dec 31, 2019 | 275,001.00 |
| Mar 31, 2019 | 29.11 Mn |
| Mar 31, 2019 | 29.11 Mn |
| Dec 31, 2017 | -27,970.00 |
| Dec 31, 2017 | -27,970.00 |
| Sep 30, 2017 | -55,089.00 |
| Sep 30, 2017 | -55,089.00 |
| Jun 30, 2017 | -16,378.00 |
| Jun 30, 2017 | -16,378.00 |
| Mar 31, 2017 | -89,284.00 |
| Mar 31, 2017 | -89,284.00 |
| Dec 31, 2016 | -347,295.00 |
| Dec 31, 2016 | -347,295.00 |
| Sep 30, 2016 | -144,093.00 |
| Sep 30, 2016 | -144,093.00 |
| Jun 30, 2016 | -118,030.00 |
| Jun 30, 2016 | -118,030.00 |